SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010589
Filing Date
2021-08-05
Accepted
2021-08-05 16:37:46
Documents
71
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nbrv-20210630x10q.htm   iXBRL 10-Q 2317037
2 EX-3.1 nbrv-20210630xex3d1.htm EX-3.1 698714
3 EX-10.1 nbrv-20210630xex10d1.htm EX-10.1 119605
4 EX-10.2 nbrv-20210630xex10d2.htm EX-10.2 69967
5 EX-10.3 nbrv-20210630xex10d3.htm EX-10.3 24266
6 EX-10.4 nbrv-20210630xex10d4.htm EX-10.4 39431
7 EX-10.5 nbrv-20210630xex10d5.htm EX-10.5 51701
8 EX-31.1 nbrv-20210630xex31d1.htm EX-31.1 10554
9 EX-31.2 nbrv-20210630xex31d2.htm EX-31.2 11269
10 EX-32.1 nbrv-20210630xex32d1.htm EX-32.1 5751
11 EX-32.2 nbrv-20210630xex32d2.htm EX-32.2 6284
  Complete submission text file 0001558370-21-010589.txt   9728565

Data Files

Seq Description Document Type Size
12 EX-101.SCH nbrv-20210630.xsd EX-101.SCH 60122
13 EX-101.CAL nbrv-20210630_cal.xml EX-101.CAL 50318
14 EX-101.DEF nbrv-20210630_def.xml EX-101.DEF 311554
15 EX-101.LAB nbrv-20210630_lab.xml EX-101.LAB 479954
16 EX-101.PRE nbrv-20210630_pre.xml EX-101.PRE 454345
17 EXTRACTED XBRL INSTANCE DOCUMENT nbrv-20210630x10q_htm.xml XML 1400193
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37558 | Film No.: 211148976
SIC: 2834 Pharmaceutical Preparations